Neoadj T-VEC May Improve Survival in Resectable Melanoma
Offering talimogene laherparepvec before surgery compared with surgery alone could improve event-free as well as overall survival in patients with advanced resectable melanoma, a new analysis suggests.
Medscape Medical News
source https://www.medscape.com/viewarticle/neoadjuvant-t-vec-may-improve-survival-resectable-melanoma-2023a1000ji5?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/neoadjuvant-t-vec-may-improve-survival-resectable-melanoma-2023a1000ji5?src=rss
Comments
Post a Comment